CI
Cigna Corporation
NYSE · Healthcare · Medical - Healthcare Plans · US
$283.44
−0.99%Year over year
Reported trailing growth
- Revenue
- +7.7%
- EBITDA
- -4.5%
- EBIT
- +6.6%
- EPS
- +31.7%
- Free cash flow
- +131.1%
- Operating cash flow
- +94.2%
Forward estimates
Based on analyst estimates
- Revenue
- +3.7%
- EBITDA
- +22.7%
- EPS
- +30.9%
Three-year CAGR
- Revenue
- +15.1%
- EBITDA
- +3.6%
- EBIT
- +2.6%
- Net income
- -3.9%
- EPS
- +1.0%
- Free cash flow
- +4.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026